Adicet Bio (ACET) Assets (2017 - 2026)
Adicet Bio (ACET) reported Assets of $148.17 million for Q2 2026, down 9.1% from $162.97 million a year earlier and down 12.5% from the prior quarter.
Analysis
Adicet Bio (ACET) Assets (2017 - 2026) Analysis & Trends
At the end of FY2025, Adicet Bio posted Assets of $192.36 million, down 12.7% from FY2024.
- Assets has a five-year compound annual growth rate of 4.6% (FY2020 to FY2025).
- By year, Assets came in at $220.22 million in FY2024 (+6.2%), $207.3 million in FY2023 (-37.3%), $330.69 million in FY2022 (-2.4%) and $338.94 million in FY2021 (+120.3%).
- Five-year quarterly Assets spans a low of $140.48 million in Q3 2025 and a high of $354.3 million in Q3 2022.
- Year over year, Assets has now declined in each of the last six quarters, with an average decline of 17.3% over the last eight quarters.
- The high point for year-over-year Assets in five years was Q4 2021 (growth of 120.3%); the low point was Q3 2025 (a decline of 42.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $169.38 million (Q1 2026), $192.36 million (Q4 2025) and $140.48 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 197.43 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Adicet Bio | 45.67 Mn | -471.74 Mn | - | 148.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 148.17 Mn |
| Mar 31, 2026 | 169.38 Mn |
| Dec 31, 2025 | 192.36 Mn |
| Sep 30, 2025 | 140.48 Mn |
| Jun 30, 2025 | 162.97 Mn |
| Mar 31, 2025 | 191.27 Mn |
| Dec 31, 2024 | 220.22 Mn |
| Sep 30, 2024 | 245.96 Mn |
| Jun 30, 2024 | 268.84 Mn |
| Mar 31, 2024 | 293.10 Mn |
| Dec 31, 2023 | 207.30 Mn |
| Sep 30, 2023 | 233.26 Mn |
| Jun 30, 2023 | 277.63 Mn |
| Mar 31, 2023 | 304.97 Mn |
| Dec 31, 2022 | 330.69 Mn |
| Sep 30, 2022 | 354.30 Mn |
| Jun 30, 2022 | 329.90 Mn |
| Mar 31, 2022 | 340.45 Mn |
| Dec 31, 2021 | 338.94 Mn |
| Sep 30, 2021 | 257.20 Mn |
API Access
Adicet Bio Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=ACET&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "ACET", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=ACET&period=max&api_key=YOUR_API_KEY");
const data = await res.json();